Jasmin Link

Pharmacokinetics and Pharmacodynamics of Twice Daily and Once Daily Regimens of Empagliflozin in Healthy Subjects

Sreeraj Macha, Tobias Brand, Thomas Meinicke et al. · Clinical Therapeutics · 2015 · 20 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis

Philip N. Newsome, Arun J. Sanyal, Guy Neff et al. · Nature Communications · 2023 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Pharmacokinetics of fixed-dose combinations of empagliflozin/metformin compared with individual tablets in healthy subjects

Christina R. Rojas, Jasmin Link, Thomas Meinicke et al. · International Journal of Clinical Pharmacology and Therapeutics · 2016 · 10 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Effects of Cytochrome P450 3A4 Induction and Inhibition on the Pharmacokinetics of BI 425809, a Novel Glycine Transporter 1 Inhibitor

Michael Desch, Glen Wunderlich, Markus Goettel et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2021 · 10 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17